New 22 Storey Science Laboratory to be Built at Canary Wharf

Life Science Industry is coming to Canary Wharf London

Canary Wharf Group and specialist Dutch developer, Kadans Science Partner, have joined forces to develop a new 22 storey laboratory in Canary Wharf. Canary Wharf’s construction and development experience, coupled with Kadans’ expertise in the development and management of life sciences buildings and ecosystems, will ensure the creation of a “world class building that will provide state of the art laboratory, office and innovation space for some of the most exciting and fast-growing businesses in the health and life sciences sector,” according to Shobi Khan, CEO Canary Wharf Group.

Largest in Europe

The 750,000 sq ft wet lab enabled building, will be the first development in what will become a centre for health and life sciences on the 3.3 hectare site at North Quay alongside the new Elizabeth Line (Crossrail) station. It’s part of Canary Wharf Group’s desire to pivot away from office space, following the drop in demand post pandemic.

When it’s completed in 2026, it will be the largest commercial wet lab enabled life science building in Europe. It will be primarily a laboratory building too, with the flexibility of having lab space on all floors.

International Designers

Designed by global architectural practice KPF, and developed using the highest sustainability and technological standards, the building will create a campus under one roof, and house SMEs and academics as well as global healthcare and pharmaceutical companies. The development will call on Kadan’s experience of creating multi-let lab and office projects within vibrant communities.

“Canary Wharf is a true live, work and play destination, with 20 acres of outdoor green space, 5 km of dockside boardwalks, hundreds of shops, restaurants and leisure facilities. We have developed 2,300 apartments on site with another 2,300 homes currently under construction and we have homes for every income level, which will enable researchers and their colleagues to live close by. There could not be a better environment for the UK’s most innovative life sciences businesses.” Shobi Khan, CEO Canary Wharf Group.

Michel Leemhuis, CEO of, Kadans Science Partner added:

“The Canary Wharf district offers exceptional connectivity, providing access to a huge talent pool and numerous funding partners from its existing tenant base, which will be a highly compelling combination for potential occupiers as well as an exceptional addition to our existing network.”